The β-Lactamase Inhibitor Boronic Acid Derivative SM23 as a New Anti-Pseudomonas aeruginosa Biofilm

is a Gram-negative nosocomial pathogen, often causative agent of severe device-related infections, given its great capacity to form biofilm. finely regulates the expression of numerous virulence factors, including biofilm production, by Quorum Sensing (QS), a cell-to-cell communication mechanism use...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in microbiology Vol. 11; p. 35
Main Authors Peppoloni, Samuele, Pericolini, Eva, Colombari, Bruna, Pinetti, Diego, Cermelli, Claudio, Fini, Francesco, Prati, Fabio, Caselli, Emilia, Blasi, Elisabetta
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 07.02.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:is a Gram-negative nosocomial pathogen, often causative agent of severe device-related infections, given its great capacity to form biofilm. finely regulates the expression of numerous virulence factors, including biofilm production, by Quorum Sensing (QS), a cell-to-cell communication mechanism used by many bacteria. Selective inhibition of QS-controlled pathogenicity without affecting bacterial growth may represent a novel promising strategy to overcome the well-known and widespread drug resistance of . In this study, we investigated the effects of SM23, a boronic acid derivate specifically designed as β-lactamase inhibitor, on biofilm formation and virulence factors production by . Our results indicated that SM23: (1) inhibited biofilm development and production of several virulence factors, such as pyoverdine, elastase, and pyocyanin, without affecting bacterial growth; (2) decreased the levels of 3-oxo-C -HSL and C -HSL, two QS-related autoinducer molecules, in line with a dampened / system; (3) failed to bind to bacterial cells that had been preincubated with conditioned medium; and (4) reduced both biofilm formation and pyoverdine production by onto endotracheal tubes, as assessed by a new model closely mimicking clinical settings. Taken together, our results indicate that, besides inhibiting β-lactamase, SM23 can also act as powerful inhibitor of biofilm, suggesting that it may have a potential application in the prevention and treatment of biofilm-associated infections.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Edited by: Silvia Buroni, University of Pavia, Italy
Reviewed by: Mona I. Shaaban, Mansoura University, Egypt; Rodolfo García-Contreras, National Autonomous University of Mexico, Mexico
These authors have contributed equally to this work
This article was submitted to Antimicrobials, Resistance and Chemotherapy, a section of the journal Frontiers in Microbiology
ISSN:1664-302X
1664-302X
DOI:10.3389/fmicb.2020.00035